This report describes one woman who was 54 years old when she had breast cancer that later spread to her thyroid gland. The patient received radiotherapy, chemotherapy, and endocrine therapy for her breast cancer. She is still alive, though the study did not report how long she has lived or any specific survival rates. Because this is a single case, the results cannot be used to predict outcomes for other patients. The main point is that doctors should suspect breast cancer if a patient with a history of the disease develops new thyroid nodules. Diagnosis often involves fine-needle aspiration and immunohistochemistry tests. Surgery is the main treatment option when needed. This information comes from a case report published as a review, which means it shares details of one experience rather than testing a broad group of people. Readers should understand that one story does not prove what happens to everyone. Always talk with a doctor about personal risks and treatment choices.
Breast cancer can spread to the thyroid gland in rare cases
Photo by Sasun Bughdaryan / Unsplash
What this means for you:
Doctors should suspect breast cancer if a patient with a history of the disease develops new thyroid nodules. More on Cancer
Network meta-analysis suggests immune checkpoint inhibitor regimens improve survival in advanced gastric cancer compared to chemotherapy alone New analysis suggests dual-target immune checkpoint inhibitors may improve survival for advanced gastric cancer patients
· May 24, 2026
PD-1/PD-L1 inhibitors improve response in dMMR/MSI-H metastatic colorectal cancer New meta-analysis shows PD-1 inhibitors improve response rates for dMMR colorectal cancer
· May 22, 2026
Meta-analysis links emotional distress to worse outcomes in advanced lung cancer Emotional distress linked to worse lung cancer survival
Frontiers · May 21, 2026
Meta-analysis reveals complex links between endocrine therapy and fertility worries in cancer patients of childbearing age Depression and endocrine therapy linked to fertility worries in cancer patients of childbearing age
Frontiers · May 19, 2026